The effects of citicoline and lamotrigine alone and in combination following permanent middle cerebral artery occlusion in rats

International Journal of Neuroscience

Volumn 114, Issue 2, 2004, Pages 183-196

  Ataus, Süreyya ^a   Önal, Mehmet Zülküf ^a   Ozdem, Sadi S ^b   Locke, Kenneth W ^c   Balkan, Sevin ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b Akdeniz University Medical Faculty   (United States)

^c Interneuron Pharmaceuticals Inc   (United States)

Author keywords

Cerebral ischemia; Citicoline; Lamotrigine; Neuroprotection; Rat

Indexed keywords

ANTICONVULSIVE AGENT; CITICOLINE; DIAGNOSTIC AGENT; LAMOTRIGINE; TETRAZOLIUM; TRIAZINE DERIVATIVE; TRIPHENYLTETRAZOLIUM;

ANALYSIS OF VARIANCE; ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBRAL ARTERY DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG SCREENING; HISTOLOGY; MALE; METHODOLOGY; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NONHUMAN; NONPARAMETRIC TEST; PATHOLOGY; RANDOMIZATION; RAT; RAT STRAIN; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANIMALS; ANTICONVULSANTS; BRAIN; BRAIN ISCHEMIA; CEREBRAL INFARCTION; CYTIDINE DIPHOSPHATE CHOLINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY, COMBINATION; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEUROLOGIC EXAMINATION; RANDOM ALLOCATION; RATS; RATS, WISTAR; STATISTICS, NONPARAMETRIC; TETRAZOLIUM SALTS; TREATMENT OUTCOME; TRIAZINES;

EID: 0842291436     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.1080/00207450490249329     Document Type: Article

References (51)

1. Alberts, M. J. (1999). Diagnosis and treatment of ischemic stroke. Reviews. American Journal of Medicine 106, 211-221.
2. Alvarez, X. A., Laredo, M., Corzo, D., Fernández-Novoa, L., Mouzo, R., & Perea, J. E., et al. (1997). Citicoline improves memory performance in elderly subjects. Methods and Findings in Expeirmental and Clinical Pharmacology, 19, 201-210.
3. Aronowski, J., Strong, R., & Grotta, J. C. (1996). Citicoline for treatment of experimental focal ischemia: Histological and behavioral outcome. Neurological Research, 18, 570-574.
4. Astrup, J., Siesjo, B. K., & Symon, L. (1981). Threshold in cerebral ischemia: The ischemic penumbra. Stroke, 12, 725.
5. Bacher, A., & Zomow, M. H. (1997). Lamotrigine inhibits extracellular glutamate accumulation during transient global cerebral ischemia in rabbits. Anesthesiology, 86, 459-463.
6. Balkan, S., Özben, T., Balkan, E., Oguz, N., Serteser, M., & Gümüşlü, S. (1997). Effects of lamotrigine on brain nitrite and cGMP levels during focal cerebral ischemia in rats. Acta Neurologica Scandinavica, 95, 140-146.
7. Bazan, N. G. (1970). Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochimica et Biophysica Acta, 218, 1-10.
8. Calabresi, P., Centonze, D., Marfia, G. A., Pisani, A., & Bernardi, G. (1999). An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons. British Journal of Pharmacology, 126, 689-696.
9. Calabresi, P., Picconi, B., Saulle, E., Centonze, D., Hainsworth, A. H., & Bernardi, G. (2000). Is pharmacological neuroprotection dependent on reduced glutamate release? Stroke, 31, 766-773.
10. Clark, W., Gunion-Rinker, L., Lessov, N., & Hazel, K. (1998). Citicoline treatment for experimental intracerebral hemorrhage in mice. Stroke, 29, 2136-2140.
11. Clarke, W. M., Warach, S. J., Pettignew, L.C., Gammans, R. E., & Sabounjian, L. A. (1997). A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group. Neurology, 49, 671-678.
12. Clarke, W. M., Williams, B. J., Selzer, K. A., Zweifler, R. M., Sabounjian, L. A., & Gammans, R. E. (1999). Citicoline Stroke Study Group: A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Stroke, 30, 2592-2597.
13. Crumrine, R. C., Bergstrand, K., Cooper, A. T., Faison, W. L., & Cooper, B. R. (1997). Lamotrigine protects hippocampal CA1 neurons from ischemic damage after cardiac arrest. Stroke, 28, 2230-2236.
14. De Medio, G. E., Brunett, M., Dorman, R. V., Droz, B., Horrocks, L. A., & Porcellati, G. (1983). Phospholipid metabolism during central and peripheral damage and recovery in nervous tissue. Original article series. Birth Defects, 19, 175-187.
15. Dorman, R. V., Dabrowiecki, Z., De Medio, G. E., Trovarelli, G., Porcellati, G. & Horroks, L. A. (1980). Control of lipid metabolism in ischemic brain CDP amines. In L. A. Horroks, G. B. Ansell, & G. Porcellati (Ed.), Phospholipids in the nervous system. Vol I: Metabolism (pp. 123-135). New York: Raven Press.
16. Dyker, A. G., & Lees, K. R. (1998). Duration of neuroprotective treatment for ischemic stroke. Stroke, 29, 535-542.
17. Finkelstein, S. P., Fisher, M., Furlan, A. J., Goldstein, L. B., Gorelick, P. B., & Kaste, M., et al. (1999). Stroke therapy academic industry roundtable. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke, 30, 2752-2758.
18. Fisher, M., Meadows, M., Do, T., Weise, J., Trubetskoy, V., & Charette, M., et al. (1995). Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. Journal of Cerebral Blood Flow and Metabolism, 15, 953-959.
19. Gilland, E., Puka-Sundvall, M., Andine, P., Bona, E., & Hagberg, H. (1994). Hypoxicischemic injury in the neonatal rat brain: Effects of pre- and post-treatment with the glutamate release inhibitor BW1003C87. Brain Research Development, 83, 79-84.
20. Hayaishi, O., Ozawa, K., Araki, C., Ishii, S., & Kondo, Y. (1961). Biochemistry of brain injury and brain edema. Japanese Journal of Medical Progress, 48, 519-539.
21. Kakihana, M., Fukuda, N., Suno, M., & Nagaoka, A. (1988). Effects of CDP-choline on neurological deficits and cerebral glucose metabolism in a rat model of cerebral ischemia. Stroke, 19, 217-222.
22. Koizumi, J., Yoshida, Y., Nakazawa, T., & Ooneda, G. (1986). Experimental studies of ischemic brain edema: I. A new experimental model of cerebral embolism in rats in recirculation can be introduced in the ischemic area. Japanese Journal of Stroke, 8, 1-8.
23. Kuwashima, J., Fujitani, B., Nakamura, K., Kadokawa, T., Yoshida, K., & Shimizu, M. (1976). Biochemical changes in unilateral brain injury in the rat: A possible role of fatty acid accumulation. Brain Research, 110, 547-557.
24. Leach, M. J., Baxter, M. G., & Critchley M. A. (1991). Neurochemical and behavioral aspects of lamotrigine. Epilepsia, 32(Suppl 2), S4-S8.
25. Leach, M. J., Marden, C. M., & Miller, A. A. (1986). Pharmacological studies on lamotrigine. a novel potential antiepileptic drug: II Neurochemical studies on the mechanism of action. Epilepsia, 27, 490-497.
26. Lyden, P. D., & Lonzo, L. (1994). Combination therapy protects ischemic brain in rats; a glutamate antagonist plus an γ-aminobutyric acid agonist. Stroke, 25, 189-196.
27. Majeswska, M. D., Strosznajder, J., & Lazarewicz, J. (1978). Effect of ischemic anoxia and barbiturate anesthesia on free radical oxidation of mitochondrial phospholipids. Brain Research, 158, 423-434.
28. Minematsu, K., & Fisher, M. (1993). MK-801 reduces extensive infarction after suture middle cerebral artery occlusion in rats. Cerebrovascular Disease, 3, 99-104.
29. Minematsu, K., Li, L., Fisher, M., Sotak, C. H., Davis, M. A., & Fiandaca, M. S. (1992). Diffusion weighted magnetic resonance imaging: Rapid and quantitative detection of focal brain ischemia. Neurology, 42, 235-240.
30. Mykita, S., Golly, F., Dreyfus, H., Freysz, L., & Massarelli, R. (1986). Effects of CDP-choline on hypocampic neurons in culture. Journal of Neurochemistry, 47, 223-2231.
31. Önal, M. Z., & Fisher, M. (1997). Acute ischemic stroke therapy: A clinical overview. European Journal of Neurology, 38, 141-154.
32. Önal, M. Z., & Fisher, M. (1996). Thrombolytic and cytoprotective therapies for acute ischemic stroke: A clinical overview. Drugs Today, 32, 573-592.
33. Önal, M. Z., Li, F., Tatlisumak, T., Locke, K. W., Sandage, B. W., & Fisher, M. (1997). Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats. Stroke, 28, 1060-1065.
34. Phillis, J. W., Song, D., & O'Regan, M. H. (1997). Inhibition by anion channel blockers of ischemia-evoked release of excitotoxic and other amino acids from rat cerebral cortex. Brain Research, 758, 9-16.
35. Rataud, J., Debemot, F., Mary, V., Pratt, S., & Stutzmann, J. M. (1994). Comparative study of voltage sensitive sodium channel blockers in focal ischemia and electric convulsions in rodents. Neuroscience Letters, 172, 19-23.
36. Scatton, B. (1994). Excitatory amino acid receptor antagonists. A novel treatment for ischemic cerebrovascular diseases. Science, 55, 25-26.
37. Schabitz, W. R., & Fisher, M. (2001). Pharmacologic neuroprotection for stroke. In M. Fisher (Ed.), Stroke therapy (pp. 275-285). Boston: Butterworth-Heinemann.
38. Schabitz, W. R., Li, F., Irie, K., Sandage, B. W., Locke, K. W., & Fisher, M. (1999). Synergistic effects of a combination of low dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia. Stroke, 30, 427-432.
39. Schabitz, W. R., Weber, J., Takano, K., Sandage, B. W., Locke, K. W., & Fisher, M. (1996). The effects of prolonged treatment with citicoline in temporary experimental focal cerebral ischemia. Journal of Neurological Sciences, 138, 21-25.
40. Shuaib, A., Mahmood, R. H., Wishart, T., Kanthan, R., Murabit, M. A., & Ijaz, S., et al. (1995). Neuroprotective effects of lamotrigine in global ischemia in gerbils: A histological, in vivo micro dialysis and behavioral study. Brain Research, 702, 199-206.
41. Smith, S. E., Lekieffre, D., Sowinski, P., & Meldrum, B. S. (1993). Cerebroprotective effect of BW619C89 after focal or global cerebral ischemia in the rat. Neuroreport, 4, 1339-1342.
42. Smith, S. E., & Meldrum, B. S. (1995). Cerebroprotective effect of lamotrigine after focal ischemia in rats. Stroke, 26, 117-122.
43. Spiers, P. A., Myers, D., Hochanadel, G. S., Lieberman, H. R., & Wurtman, R. J. (1996). Citicoline improves verbal memory in aging. Archives of Neurology, 53, 441-448.
44. Trovarelli, G., De Medio, G. E., Dorman, R. V., Piccinin, G. L., Horrocks, L. A., & Porcellatti, G. (1981). Effect of cytidine diphosphate choline (CDP-choline) on ischemia-induced alterations of brain lipid in the gerbil. Neurochemical Research, 6, 821-833.
45. Wang, S. J., Huang, C. C., Hsu, K. S., Tsai, J. J., & Gean, P. W. (1996). Presynaptic inhibition of excitatory neurotransmission by lamotrigine in the rat amygdalar neurons. Synapse, 24, 248-255.
46. Weiss, G. B. (1995). Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline. Life Science, 56, 637-660.
47. Wiard, R. P., Dickerson, M. C., Beek, O., Norton, R., & Cooper, B. R. (1995). Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia. Stroke, 26, 466-472.
48. Yamamoto, M., Shimizu, M., & Okamiya, H. (1990). Pharmacological actions of a new TRH analogue, YM-14673, in rats subjected to cerebral ischemia and anoxia. European Journal of Pharmacology, 181, 207-214.
49. Yatsu, F. M., & Moss, S. A. (1971). Brain lipid changes following hypoxia. Stroke, 2, 587-593.
50. Zea, L. E., Weinstein, P. R., Carlson, S., & Cummins, R. (1989). Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 20, 84-91.
51. Zivin, J. A. (1998). Current status of new drug development for ischemic stroke. In M. Fisher. (Ed.), Monographs in clinical neuroscience (pp 128-138). Basel: Karger.